by Nordic Pharma | Aug 9, 2021 | News
August 5, 2021 Amring Pharmaceuticals Inc., a niche brand and generic pharmaceuticals company, announced today that it has received FDA approval for generic Isoproterenol Hydrochloride USP and has immediately begun commercialization activity. Read...
by Jamie Robinson | Jun 28, 2019 | News
June 24, 2019 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it has launched two valued drugs into its generic portfolio and to the U.S. Market: Succinylcholine Chloride Injection, a generic...
by Jamie Robinson | Jan 9, 2019 | News
January 4, 2019 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical and ophthalmic medical device company, announced today that it launched a generic oncology drug, Arsenic Trioxide Injection in November 2018 and expects to launch four (4) additional...
by Jen G | Jul 25, 2018 | News
July 17, 2018 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (ophthalmic viscosurgical device). Amring is excited to offer this new, cost-effective device and position itself in the...
by Mike H | Jun 30, 2017 | News
June 30, 2017 Amring Pharmaceuticals Inc. today announced that it is a recipient of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement company. One of 11 suppliers to receive the award this year, Amring Pharmaceuticals Inc. was recognized...
Recent Comments